Cadmium-induced inhibition of the growth and metastasis of human lung carcinoma xenografts: Role of apoptosis

Carcinogenesis

Volumn 20, Issue 1, 1999, Pages 65-70

  Waalkes, Michael P ^a   Diwan, Bhalchandra A ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM; DRINKING WATER; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; LUNG CARCINOMA; LUNG METASTASIS; LUNG SMALL CELL CANCER; LUNG TUMOR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CADMIUM CHLORIDE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; HUMANS; INJECTIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; SUBRENAL CAPSULE ASSAY; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032897354     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.1.65     Document Type: Article

References (48)

1. Waalkes, M.P., Diwan, B.A., Weghorst, C.M., Ward, J.M. and Rice, J.M. (1991) Anti-carcinogenic effects of cadmium in B6C3F1 mouse liver and lung. Toxicol. Appl. Pharmacol., 110, 327-335.
2. Waalkes, M.P., Diwan, B.A., Weghorst, C.M., Ward, J.M., Rice, J.M., Cherian, M.G. and Goyer, R.A. (1993) Further evidence of the tumor-suppressive effects of cadmium in the B6C3F1 mouse liver and lung; late stage vulnerability of tumors to cadmium and the role of metallothionein. J. Pharmacol. Exp. Ther., 266, 1656-1663.
3. Waalkes, M.R. Diwan, B.A., Rehm, S., Moussa, M., Cherian, M.G. and Goyer, R.A. (1996) Down-regulation of metallothionein expression in human and murine hepatocellular tumors; association with the tumor-necrotizing and antineoplastic effect of cadmium in mice. J. Pharmacol. Exp. Ther., 277, 1026-1033.
4. Matsumoto, Y., Oka, M., Sakamoto, A., Narasaki, F., Fukuda, M., Takatani, H., Terashi, K., Tsurutani, J., Nagashima, S., Soda, H. and Kohno, S. (1997) Enhanced expression of metallothionein in human non-small-cell lung carcinomas following chemotherapy. Anticancer Res., 17, 3777-3780.
5. Lohmann, R.D. and Beyersmann, D. (1994) Effects of zinc and cadmium on apoptotic DNA fragmentation in isolated bovine liver nuclei. Environ. Health Perspect., 102, 269-271.
6. 1 cells. Life Sci., 56, 351-356.
7. El Azzouzi, B., Tsangaris, G.T., Pellegrini, O., Manuel, Y., Benveniste, J. and Thomas, Y. (1994) Cadmium induces apoptosis in human T cell line. Toxicology, 88, 127-139.
8. Habeebu, S.S., Liu, J. and Klaassen, C.D. (1998) Cadmium-induced apoptosis in mouse liver. Toxicol. Appl. Pharmacol., 149, 203-209.
9. Yan, H., Carter, C.E., Xu, C., Singh, P.K., Jones, M.M., Johnson, J.E. and Dietrich, M.S. (1997) Cadmium-induced apoptosis in the urogenital organs of the male rat and its suppression by chelation. J. Toxicol. Environ. Health, 52, 149-168.
10. Williams, G.T. (1991) Programmed cell death: apoptosis and oncogenesis. Cell, 65, 1097-1098.
11. Korsmeyer, S.J. (1992) Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood, 80, 879-886.
12. Oltvai, Z.N., Milliman, C.L. and Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74, 587-608.
13. Gazzaniga, P., Gradilone, A., Vercillo, R., Gandini, P., Silvestri, I., Napolitano, M., Vincenzoni, A., Gallucci, M. and Agliano, A.M. (1996) Bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer. Int. J. Cancer, 69, 100-104.
14. Knudson, C.M. and Korsmeyer, S.J. (1997) Bcl-2 and Bax function independently to regulate cell death. Nature Genet., 16, 358-363.
15. Hockenbery, D.M., Zutter, M., Hickey, W., Nahm, M. and Korsmeyer, S.J. (1991) Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl Acad. Sci. USA, 88, 6961-6965.
16. Colombel, M., Symmans, F., Gil, S., Otoole, K.M., Chopin, D., Benson, M., Olsson, C.A., Korsmeyer, S. and Buttyan, R. (1993) Detection of the apoptosis-suppressing oncoprotein in Bcl-2 in hormone-refractory human prostate cancers. Am. J. Pathol., 143, 390-400.
17. Pezzella, F., Turley, H., Kuzu, I., Tungekar, M.F., Dunnill, M.S., Pierce, C.B., Harris, A., Gatter, K.C. and Mason, D.Y. (1993) Bcl-2 protein in non-small-cell lung carcinoma. N. Engl. J. Med., 329, 690-694.
18. Ikegaki, N., Katsumata, M., Minna, J. and Tsujimoto, Y. (1994) Expression of Bcl-2 in small cell lung carcinoma cells. Cancer Res., 54, 6-8.
19. Hague, A., Moorghen, M., Hicks, D., Chapman, M. and Paraskeva, C. (1994) Bcl-2 expression in human colorectal adenomas and carcinomas. Oncogenes, 9, 3367-3370.
20. Kapucuoglu, N., Losi, L. and Eusebi, V (1997) Immunohistochemical localization of Bcl-2 and Bax proteins in in situ and invasive duct breast carcinomas. Virchows Arch., 430, 17-22.
21. Krajewska, M., Fenoglio-Preiser, C.M., Krajewski, S., Song, K., MacDonald, J.S., Stemmerman, G. and Reed, J.C. (1996) Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am. J. Pathol., 149, 1449-1457.
22. Keane, T.E., Rosner, G.L., Gingrich, J.R., Poulton, S.H. and Walther, P.J. (1991) The therapeutic impact of dipyridamole: chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer. J. Urol., 146, 1418-1424.
23. Yamauchi, M., Satta, T., Ito, A., Kondo, K., Akiyama, S., Ito, K., Watanabe, T. and Takagi, H. (1991) Subrenal capsule assay using nude mice as a predictor of the response of the gastric cancer to chemotherapy. J. Surg. Oncol., 47, 98-101.
24. Rajnay, J., Kopper, L. and Lapis, K. (1987) Chemotherapeutic response of squamous cell carcinoma xenografts (subcutaneous and capsule assay). Oncology, 44, 307-311.
25. Boghaert, E.R., Distelmans, W., Van Ginckel, R. and Mareel, M.M. (1987) Numerical evaluation of the kidney invasion test. Invasion Metastasis, 7, 230-241.
26. Hahka-Kemppinen, M., Muhonen, T., Kangas, L. and Pyrhonen, S. (1996) Chemosensitivity of human melanoma metastases in mouse subrenal capsule assay - can it predict response to combined cytostatic plus interferon therapy in metastatic melanoma? Melanoma Res., 6, 215-221.
27. Muhonen, T., Pyrhonen, S., Laasonen, A., Wasenius, V.M., Asko-Seljavaara, S., Franssila, K. and Kangas, L. (1992) Tumour growth rate and DMA flow cytometry parameters as prognostic factors in metastatic melanoma. Br. J. Cancer, 66, 528-532.
28. Miyake, H., Hara, I., Yoshimura, K., Eto, H., Arakawa, S., Wada, S., Chihara, K. and Kamidono, S. (1996) Introduction of basic fibroblast growth factor gene into mouse renal carcinoma cell line enhances its metastatic potential. Cancer Res., 56, 2440-2445.
29. Grossi, F.S., Zhao, X., Romijn, J.C., ten Kate, F.J. and Schroder, F.H. (1992) Metastatic potential of human renal carcinoma: experimental model using subrenal capsule implantation in athymic nude mice. Urol. Res., 20, 303-306.
30. Goering, P.L., Waalkes, M.P. and Klaassen, C.D. (1994) Toxicology of cadmium. In Goyer, R.A. and Cherian, M.G. (eds) Handbook of Experimental Pharmacology, Vol. 115. Toxicology of Metals, Biochemical Effects. Springer-Verlag, New York, NY, pp. 189-214.
31. IARC (1993) IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans: Beryllium, Cadmium, Mercury and Exposures in The Glass Industry. IARC Scientific Publications no. 58, IARC, Lyon, pp. 119-238.
32. Abshire, M.K., Devor, D.E., Diwan, B-A., Shaughnessy, J.D. Jr and Waalkes, M.P. (1996) In vitro exposure to cadmium in rat L6 myoblasts can result in both enhancement and suppression of malignant progression in vivo. Carcinogenesis, 17, 1349-1356.
33. Kerkvliet, N.I., Koller, L.D., Baecher, L.G. and Brauner, J.A. (1979) Effect of cadmium exposure on primary tumor growth and cell-mediated cytotoxicity in mice bearing MSB sarcomas. J. Natl Cancer Inst., 63, 479-483.
34. Gray, I., Arrieh, M. and Balter, N.J. (1982) Cadmium modification of response in BALB/c mice to MOPC-104E tumor. Arch. Environ. Health, 37, 342-345.
35. 2 on Dunn osteosarcoma. Nippon Seikeigeka Gakkai Zasshi, 64, 70-75.
36. Shimada, H., Shiao, Y.-L., Shibata, M.-A. and Waalkes, M.P. (1998) Cadmium suppresses apoptosis induced by chromium. J. Toxicol. Environ. Health, 55, 101-110.
37. Shimmi, M., Hochadel, J.F., Abshire, M.K. and Waalkes, M.P. (1997) Effects of glutathione depletion on cadmium-induced cytotoxicity and protooncogene activation in cultured rat myoblasts. J. Toxicol. Environ. Health, 51, 609-621.
38. Misra, R.R., Hochadel, J.F., Smith, G.T., Cook, J.C., Waalkes, M.P. and Wink, D.A. (1996) Evidence that nitric oxide enhances cadmium toxicity by release of the metal from metallothionein. Chem. Res. Toxicol., 9, 326-332.
39. Liu, J., Kershaw, W.C. and Klaassen, C.D. (1990) Rat primary hepatocyte cultures are a good model for examining metallothionein-induced tolerance to cadmium toxicity. In Vitro Cell Dev. Biol., 26, 75-79.
40. Stacey, N.H., Cantilena, L.R. and Klaassen, C.D. (1980) Cadmium toxicity and lipid peroxidation in isolated rat hepatocytes. Toxicol. Appl. Pharmacol., 53, 470-480.
41. Waalkes, M.P. and Goering, P.L. (1990) Metallothionein and other cadmium-binding proteins: recent developments. Chem. Res. Toxicol., 3, 281-288.
42. Masters, B.A., Kelly, E.J., Quaife, C.J., Brinster, R.L. and Palmiter, R.D. (1994) Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl Acad. Sci. USA, 91, 584-588.
43. Waalkes, M.P., Nagamine, T., Shimada, H., Diwan, B.A., Coogan, T.P., Shiraishi, N., Cherian, M.G. and Goyer, R.A. (1998) Further studies on the role of metallothionein in the antitumor effects of cadmium. In Klaassen, C.D. (ed.) Advances in Life Sciences; Metallothionein 1997. Birkhauser Verlag, Basel, Switzerland.
44. Zhao, C.Q., Young, M.R., Diwan, B.A., Coogan, T.P. and Waalkes, M.P. (1997) Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl Acad. Sci. USA, 94, 10907-10912.
45. Waalkes, M.P. and Klaassen, C.D. (1985) Concentration of metallothionein in major organs of rats after administration of various metals. Fundam. Appl. Toxicol., 5, 473-477.
46. Misra, R.R., Crance, K.A., Bare, R.M. and Waalkes, M.P. (1997) Strain and species comparison of cadmium disposition and metallothionein gene expression in rats and mice. Toxicology, 117, 99-109.
47. Calabresi, P. and Chabner, B.A. (1996) Chemotherapy of neoplastic disease; introduction. In Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W. and Goodman, A.G. (eds) Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th Edn. McGraw-Hill, New York, NY, pp. 1225-1232.
48. IARC (1987) IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans: Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, Supplement 7, IARC, Lyon.